Geneoscopy cover photo
Geneoscopy

Geneoscopy

生物技术研究

St. Louis,MO 6,854 位关注者

Cancer Prevention | Diagnostics | Precision Medicine

关于我们

Geneoscopy Inc. is a life sciences company focused on developing diagnostic tests for gastrointestinal health. Leveraging its proprietary, patented stool-derived eukaryotic RNA (seRNA) biomarker platform, Geneoscopy’s mission is to empower patients and providers to transform gastrointestinal health through innovative diagnostics. The company’s FDA-approved ColoSense? test uses a proprietary RNA-based platform to screen for colorectal cancer and advanced adenomas for average-risk individuals over the age of 45. In partnership with leading universities and biopharmaceutical companies, Geneoscopy is also developing diagnostic tests for treatment selection and therapy monitoring in other GI disease areas. For more information, visit www.geneoscopy.com and follow the company on LinkedIn.

网站
https://geneoscopy.com
所属行业
生物技术研究
规模
51-200 人
总部
St. Louis,MO
类型
私人持股
创立
2015
领域
Life Sciences、Noninvasive Diagnostic Screening、Colorectal Cancer Screening、GI Health、GI Disease Companion Diagnostics、seRNA、RNA Biomarkers、Precision Medicine Partnerships和IBD

地点

  • 主要

    2220 Welsch Industrial Ct

    US,MO,St. Louis,63146

    获取路线

Geneoscopy员工

动态

相似主页

查看职位

融资